VMS Rehab Systems, Inc.
$0.00+0.00%(+$0.00)
TickerSpark Score
48/100
73
Valuation
60
Profitability
55
Growth
20
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VRSYF research report →
52-Week Range100% of range
Low $0.00
Current $0.00
High $0.00
Companywww.vmsrehabsystemsinc.com
VMS Rehab Systems, Inc. engages in generic drug and home healthcare businesses. It develops and tests generic tadalafil products.
- CEO
- Michael S. Wexler
- IPO
- 2015
- HQ
- Ottawa, ON, CA
Price Chart
+0.00% · this period
Valuation
- Market Cap
- $156.17K
- P/E
- 0.00
- P/S
- 2178.02
- P/B
- -0.00
- EV/EBITDA
- -2280.07
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -14.56%
- Op Margin
- -95.76%
- Net Margin
- 64.78%
- ROE
- -20.14%
- ROIC
- 108.33%
Growth & Income
- Revenue
- $71.701 · 19.67%
- Net Income
- $46.445 · 639.87%
- EPS
- $0.17 · 0.00%
- Op Income
- $-68.661
- FCF YoY
- -21.19%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 9.21
- Avg Volume
- 7.07K
Get TickerSpark's AI analysis on VRSYF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our VRSYF Coverage
We haven't published any research on VRSYF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VRSYF Report →